“…Strains of MRCNS are often linked to multi-resistance, like their MRSA counterparts, thus presenting an ongoing therapeutic challenge (Mongkolrattanothai et al, 2004;Noto et al, 2006). Jones et al (2003) in a study testing the susceptibility of only skin and soft tissue isolates in 283 US hospitals and 301 hospitals in Europe for 9 antimicrobials, including amoxicillin-clavulanate, cefotaxine, cetriaxone, ciprofloxacin, erythromycin, gentamicin, levofloxacin, trimethoprim/sulfamethaoxazole and vancomycin revealed that almost all MSCNS isolates were susceptible to amoxicillin-clavulanate. In this study, all the isolates were resistant to amoxicillin-clavulanate, 33% of isolates were resistant to gentamicin, and 72% showed resistance to trimethoprime/sulfamathoxazole, while all were resistant to vancomycin.…”